VYGR
VYGR
NASDAQ · Biotechnology

Voyager Therapeutics Inc

$3.68
+0.14 (+3.95%)
As of Feb 8, 2:04 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 42.84M 42.57M 38.58M
Net Income -111,494 -129,666 -108,514
EPS
Profit Margin -0.3% -0.3% -0.3%
Rev Growth -2.8% +21.1% -3.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 63.61M 56.86M 64.95M
Total Equity 183.41M 186.28M 172.57M
D/E Ratio 0.35 0.31 0.38
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -145,096 -158,434 -135,051
Free Cash Flow -87,273 -114,389 -110,539